Author:
Berezhnoy D. S.,Troshev D. V.,Kulikova O. I.,Abaimov D. A.,Muzychuk O. A.,Stvolinsky S. L.,Fedorova T. N.
Subject
Physiology (medical),Physiology
Reference31 articles.
1. Müller, T., Catechol-O-methyltransferase inhibitors in Parkinson’s disease, Drugs, 2015, vol. 75, no. 2, pp. 157–174.https://doi.org/10.1007/s40265-014-0343-025559423
2. Mahlknecht, P., Seppi, K., and Poewe, W., The concept of prodromal Parkinson’s disease, J. Parkinson’s Dis., 2015, vol. 5, no. 4, pp. 681–697.https://doi.org/10.3233/JPD-15068526485429
3. Vingill, S., Connor-Robson, N., and Wade-Martins, R., Are rodent models of Parkinson’s disease behaving as they should? Behav. Brain Res., 2018, vol. 15, no. 352, pp. 133–141.https://doi.org/10.1016/j.bbr.2017.10.02129074404
4. Braak, H., Ghebremedhin, E., Rüb, U., Bratzke, H., and Del Tredici, K., Stages in the development of Parkinson’s disease-related pathology, Cell Tissue Res., 2004, vol. 318, no. 1, pp. 121–134.https://doi.org/10.1007/s00441-004-0956-915338272
5. Cheesman, A. and Piccini, P., Functional imaging of movement disorders, Adv. Clin. Neurosci. Rehabil., 2004, vol. 4, pp. 10–13.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献